Dermatology · San Diego, CA
NPI
1932307030
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7060 Clairemont Mesa Blvd
San Diego, CA, 92111
Phone (858) 573-5399
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,791
30 services
Medicare patients, 2024
17
Average age 63
Drug cost, 2024
$613K
2,350 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Allen Benabio prescribed most often to Medicare patients was Clobetasol Propionate, with 270 prescriptions and refills. In total Jeffrey Allen Benabio wrote 2,350 Medicare prescriptions that cost $613K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 270 | 281 | 117 | $5,788 |
| Triamcinolone Acetonide Generic | 264 | 311 | 155 | $5,303 |
| Ketoconazole Generic | 225 | 232 | 96 | $3,413 |
| Tacrolimus Generic | 144 | 148 | 75 | $11K |
| Fluocinonide Generic | 113 | 115 | 64 | $1,656 |
| Fluorouracil Generic | 113 | 113 | 87 | $4,280 |
| Retin-A Tretinoin | 100 | 117 | 41 | $3,171 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 96 | 107 | 44 | $3,200 |
| Doxycycline Monohydrate Generic | 88 | 106 | 48 | $2,213 |
| Metronidazole Generic | 74 | 78 | 40 | $1,162 |
| Alclometasone Dipropionate Generic | 70 | 72 | 40 | $4,961 |
| Ciclopirox Generic | 64 | 64 | 33 | $1,107 |
| Mupirocin Generic | 52 | 53 | 22 | $541 |
| Otezla Apremilast | 47 | 47 | Under 11 | $203K |
| Clindamycin Phosphate Generic | 46 | 46 | 22 | $1,021 |
Brand drugs: 273 claims; generic drugs: 2,077 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jeffrey Allen Benabio were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.